Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Jacques Robert. (1998) Approaches to multidrug resistance reversal. Expert Opinion on Investigational Drugs 7:6, pages 929-939.
Read now
Read now
Articles from other publishers (36)
Richard Callaghan. (2015) Providing a molecular mechanism for P-glycoprotein; why would I bother?. Biochemical Society Transactions 43:5, pages 995-1002.
Crossref
Crossref
Joseph H. Chou, Tai‐Tsung Chang & Ting‐Chao Chou. 2005. The Cancer Handbook. The Cancer Handbook.
Pornngarm Limtrakul. 2007. The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease. The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease
269
300
.
Ting‐Chao Chou & Tai‐Tsung Chang. 2005. The Cancer Handbook. The Cancer Handbook.
Chatchanok Loetchutinat, François Chau & Samlee Mankhetkorn. (2003) Synthesis and Evaluation of 5-Aryl-3-(4-hydroxyphenyl)-1,3,4-oxadiazole-2-(3H)-thiones as P-Glycoprotein Inhibitors. Chemical and Pharmaceutical Bulletin 51:6, pages 728-730.
Crossref
Crossref
E. Teodori, S. Dei, S. Scapecchi & F. Gualtieri. (2002) The medicinal chemistry of multidrug resistance (MDR) reversing drugs. Il Farmaco 57:5, pages 385-415.
Crossref
Crossref
Brenda D. Stride, Susan P.C. Cole & Roger G. Deeley. (1999) Localization of a Substrate Specificity Domain in the Multidrug Resistance Protein. Journal of Biological Chemistry 274:32, pages 22877-22883.
Crossref
Crossref
Samlee Mankhetkorn, Elisabetta Teodori & Arlette Garnier-Suillerot. (1999) Partial inhibition of the P-glycoprotein-mediated transport of anthracyclines in viable resistant K562 cells after irradiation in the presence of a verapamil analogue. Chemico-Biological Interactions 121:2, pages 125-140.
Crossref
Crossref
J. Robert. (1999) Multidrug resistance in oncology: diagnostic and therapeutic approaches. European Journal of Clinical Investigation 29:6, pages 536-545.
Crossref
Crossref
Michel Demeule, Alain Laplante, Arash Sepehr-Araé, Édith Beaulieu, Diana Averill-Bates, Roland M Wenger & Richard Béliveau. (1999) Inhibition of P-glycoprotein by cyclosporin A analogues and metabolites. Biochemistry and Cell Biology 77:1, pages 47-58.
Crossref
Crossref
Jacques Robert. (1998) Resistance to Anticancer Drugs: Are We Ready to Use Biologic Information for the Treatment of Patients With Cancer?. Therapeutic Drug Monitoring 20:5, pages 581-587.
Crossref
Crossref
Elene Pereira, Jolanta Tarasiuk & Arlette Garnier-Suillerot. (1998) Kinetic analysis in living cells of the inhibition of the P-glycoprotein-mediated efflux of anthracyclines by vinca alkaloids. Chemico-Biological Interactions 114:1-2, pages 61-76.
Crossref
Crossref
Nadia Romiti, Roberto Tongiani, Fabrizio Cervelli & Elisabetta Chieli. (1998) Effects of curcumin on P-glycoprotein in primary cultures of rat hepatocytes. Life Sciences 62:25, pages 2349-2358.
Crossref
Crossref
Vallabhaneni V Rao, Lee W Herman, James F Kronauge & David Piwnica-Worms. (1998) A Novel Areneisonitrile Tc Complex Inhibits the Transport Activity of MDR P-Glycoprotein. Nuclear Medicine and Biology 25:3, pages 225-232.
Crossref
Crossref
Lucille Beaudet, Ina L. Urbatsch & Philippe Gros. 1998. ABC Transporters: Biochemical, Cellular, and Molecular Aspects. ABC Transporters: Biochemical, Cellular, and Molecular Aspects
397
413
.
Catherine Martin, Georgina Berridge, Christopher F. Higgins & Richard Callaghan. (2009) The multi‐drug resistance reversal agent SR33557 and modulation of vinca alkaloid binding to P‐glycoprotein by an allosteric interaction. British Journal of Pharmacology 122:4, pages 765-771.
Crossref
Crossref
Richard Callaghan, Georgina Berridge, David R Ferry & Christopher F Higgins. (1997) The functional purification of P-glycoprotein is dependent on maintenance of a lipid–protein interface. Biochimica et Biophysica Acta (BBA) - Biomembranes 1328:2, pages 109-124.
Crossref
Crossref
Stefania Scala, Nadia Akhmed, U. S. Rao, Ken Paull, Lu-Bin Lan, Bruce Dickstein, Jong-Seok Lee, Galal H. Elgemeie, Wilfred D. Stein & Susan E. Bates. (1997) P-Glycoprotein Substrates and Antagonists Cluster into Two Distinct Groups. Molecular Pharmacology 51:6, pages 1024-1033.
Crossref
Crossref
Yan Ping Hu & Jacques Robert. (1997) Inhibition of protein kinase C in multidrug-resistant cells by modulators of multidrug resistance. Journal of Cancer Research and Clinical Oncology 123:4, pages 201-210.
Crossref
Crossref
Michel Demeule, Roland M. Wenger & Richard Béliveau. (1997) Molecular Interactions of Cyclosporin A with P-glycoprotein. Journal of Biological Chemistry 272:10, pages 6647-6652.
Crossref
Crossref
A. Garnier-Suillerot. 1997. Cytotoxic, Mutagenic and Carcinogenic Potential of Heavy Metals Related to Human Environment. Cytotoxic, Mutagenic and Carcinogenic Potential of Heavy Metals Related to Human Environment
323
347
.
Yan-Ping Hu, Christiane Chapey & Jacques Robert. (1996) Relationship between the inhibition of azidopine binding to P-glycoprotein by MDR modulators and their efficiency in restoring doxorubicin intracellular accumulation. Cancer Letters 109:1-2, pages 203-209.
Crossref
Crossref
Samlee Mankhetkorn, Elisabetta Teodori, Serena Scapecchi & Arlette Garnier-Suillerot. (1996) Study of P-glycoprotein functionality in living resistant K562 cells after photolabeling with a verapamil analogue. Biochemical Pharmacology 52:2, pages 213-217.
Crossref
Crossref
D.W. Loe, R.G. Deeley & S.P.C. Cole. (1996) Biology of the multidrug resistance-associated protein, MRP. European Journal of Cancer 32:6, pages 945-957.
Crossref
Crossref
Douglas W. Loe, Kurt C. Almquist, Roger G. Deeley & Susan P.C. Cole. (1996) Multidrug Resistance Protein (MRP)-mediated Transport of Leukotriene C4 and Chemotherapeutic Agents in Membrane Vesicles. Journal of Biological Chemistry 271:16, pages 9675-9682.
Crossref
Crossref
Michael Soldan & Edmund Maser. 1997. Enzymology and Molecular Biology of Carbonyl Metabolism 6. Enzymology and Molecular Biology of Carbonyl Metabolism 6
537
544
.
G. Toffoli, F. Simone, G. Corona, M. Raschack, B. Cappelletto, M. Gigante & M. Boiocchi. (1995) Structure-activity relationship of verapamil analogs and reversal of multidrug resistance. Biochemical Pharmacology 50:8, pages 1245-1255.
Crossref
Crossref
David Piwnica-Worms, Vallabhaneni V. Rao, James F. Kronauge & James M. Croop. (2002) Characterization of Multidrug Resistance P-Glycoprotein Transport Function with an Organotechnetium Cation. Biochemistry 34:38, pages 12210-12220.
Crossref
Crossref
Lucille Beaudet & Philippe Gros. (1995) Functional Dissection of P-glycoprotein Nucleotide-binding Domains in Chimeric and Mutant Proteins. Journal of Biological Chemistry 270:29, pages 17159-17170.
Crossref
Crossref
Hu Yan Ping & Jacques Robert. (1995) Azelastine and flezelastine as reversing agents of multidrug resistance: Pharmacological and molecular studies. Biochemical Pharmacology 50:2, pages 169-175.
Crossref
Crossref
Y.-P. Hu, N. Henry-Toulmé & J. Robert. (1995) Failure of liposomal encapsulation of doxorubicin to circumvent multidrug resistance in an in vitro model of rat glioblastoma cells. European Journal of Cancer 31:3, pages 389-394.
Crossref
Crossref
S. Ruetz & P. Gros. (1994) Functional expression of P-glycoproteins in secretory vesicles.. Journal of Biological Chemistry 269:16, pages 12277-12284.
Crossref
Crossref
Therese Thalhammer, Verena Stapf, Leszek Gajdzik & Jürg Graf. (1994) Bile canalicular cationic dye secretion as a model for P-glycoprotein mediated transport. European Journal of Pharmacology: Environmental Toxicology and Pharmacology 270:2-3, pages 213-220.
Crossref
Crossref
Nomita H. Patel & Mace L. Rothenberg. (1994) Multidrug resistance in cancer chemotherapy. Investigational New Drugs 12:1, pages 1-13.
Crossref
Crossref
Doug W. Loe & Frances J. Sharom. (1994) Interaction of multidrug-resistant Chinese hamster ovary cells with the peptide ionophore gramicidin D. Biochimica et Biophysica Acta (BBA) - Biomembranes 1190:1, pages 72-84.
Crossref
Crossref
Frits A. de Wolf, Rutger W. H. M. Staffhorst, Hans Peter Smits, Michel F. Onwezen & Ben de Kruijff. (2002) Role of anionic phospholipids in the interaction of doxorubicin and plasma membrane vesicles: Drug binding and structural consequences in bacterial systems. Biochemistry 32:26, pages 6688-6695.
Crossref
Crossref